Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2048514rdf:typepubmed:Citationlld:pubmed
pubmed-article:2048514lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0002978lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0015846lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0026056lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0002766lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C0600097lld:lifeskim
pubmed-article:2048514lifeskim:mentionsumls-concept:C1696465lld:lifeskim
pubmed-article:2048514pubmed:issue1lld:pubmed
pubmed-article:2048514pubmed:dateCreated1991-7-12lld:pubmed
pubmed-article:2048514pubmed:abstractTextSafety and efficacy of two drug regimens used for sedation and analgesia during lower-extremity angiography were studied. Midazolam (loading dose 14.5 micrograms/kg; maintenance dose, 7.2 micrograms/kg) with or without fentanyl (loading dose, 0.725 micrograms/kg; maintenance dose, 0.362 micrograms/kg) was administered in a blind fashion as an IV bolus to 50 patients. Hemodynamic responses were monitored, and a standardized questionnaire was given to the patient before, immediately after, and 8-24 hr after the procedure. Physicians also were asked questions after the procedure. Heart rate and oxygen saturation were not significantly different before and 2 min after administration or between groups. A small but significant decrease in blood pressure occurred 2 min after the loading dose was given in both groups. Both drug regimens had statistically significant anxiolytic effects; however, anxiolytic effects were superior in the midazolam/fentanyl group (p less than .02). Patients rated the overall effectiveness of anesthesia with midazolam/fentanyl as superior (p less than .02). Analysis of physicians' judgments of the effectiveness of sedation and analgesia showed a statistically significant advantage for the midazolam/fentanyl group (p less than .01). We conclude that midazolam/fentanyl appears to be as safe as and more efficacious than midazolam alone for sedation and analgesia during lower-extremity angiography.lld:pubmed
pubmed-article:2048514pubmed:languageenglld:pubmed
pubmed-article:2048514pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2048514pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2048514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2048514pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2048514pubmed:statusMEDLINElld:pubmed
pubmed-article:2048514pubmed:monthJullld:pubmed
pubmed-article:2048514pubmed:issn0361-803Xlld:pubmed
pubmed-article:2048514pubmed:authorpubmed-author:SmithT PTPlld:pubmed
pubmed-article:2048514pubmed:authorpubmed-author:NakagawaNNlld:pubmed
pubmed-article:2048514pubmed:authorpubmed-author:BerbaumK SKSlld:pubmed
pubmed-article:2048514pubmed:authorpubmed-author:CraggA HAHlld:pubmed
pubmed-article:2048514pubmed:issnTypePrintlld:pubmed
pubmed-article:2048514pubmed:volume157lld:pubmed
pubmed-article:2048514pubmed:ownerNLMlld:pubmed
pubmed-article:2048514pubmed:authorsCompleteYlld:pubmed
pubmed-article:2048514pubmed:pagination173-6lld:pubmed
pubmed-article:2048514pubmed:dateRevised2008-2-15lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:meshHeadingpubmed-meshheading:2048514-...lld:pubmed
pubmed-article:2048514pubmed:year1991lld:pubmed
pubmed-article:2048514pubmed:articleTitleRandomized double-blind trial of midazolam/placebo and midazolam/fentanyl for sedation and analgesia in lower-extremity angiography.lld:pubmed
pubmed-article:2048514pubmed:affiliationUniversity of Iowa College of Medicine, Department of Radiology, Iowa City 52242.lld:pubmed
pubmed-article:2048514pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2048514pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2048514pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2048514pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2048514lld:pubmed